Sign Up
HB 7192 Connecticut House · 2025 Regular Session

AN ACT IMPLEMENTING RECOMMENDATIONS OF THE BIPARTISAN DRUG TASK FORCE.

HB 7192, now Public Act 25-167, implements recommendations from a bipartisan drug task force. The law directs state agencies to adopt specific actions aimed at addressing drug policy, though the exact provisions are not detailed in the provided context. It affects state agencies responsible for drug prevention, treatment, and public health initiatives, as outlined by the task force's proposals. The bill was signed into law by the governor on July 8, 2025, making these recommendations official state policy.
Issues: ✓ HealthcareSupports HealthcareBill implements drug task force recommendations for prevention/treatment, advancing public health initiatives under healthcare topic as per subjects and summary.85% confidence
Bill status signed all 5 stages cleared
Introduction
Mar 2025
Committee Review
May 2025
House Passage
Jun 2025
Senate Passage
Jun 2025
Signed into Law
Jul 2025
Introduced Mar 6, 2025 Signed Jul 8, 2025
Maddy AI version diff · 1 comparison

What changed between versions

Raised Bill → APP Joint Favorable Substitute · 4 edits
MODERATE
The bill was amended to strengthen protections against pharmacy benefit managers and health carriers from using contracts that force pharmacists to hide cost information or violate fiduciary duties. The substitute version adds a new requirement prohibiting contracts entered into after October 1, 2025, from containing provisions that allow parties to violate fiduciary duties owed to covered persons. It also expands the definition of insurance practice violations to include specific sections of the general statutes.
Scope change
The bill's scope remains focused on pharmacy services contracts, but the fiduciary duty protection now applies to contracts entered into after October 1, 2025, rather than being a general prohibition.
REQUIREMENT

Added a new provision prohibiting contracts entered into after October 1, 2025, from containing provisions that permit or require parties to violate the fiduciary duty owed to covered persons.

ENFORCEMENT

Expanded the definition of insurance practice violations to include sections 38a-815 through 38a-819 of the general statutes, rather than just section 38a-815.

TECHNICAL

Removed the requirement that contracts must not contain provisions penalizing pharmacists for disclosing prescription costs or alternative purchasing options (this was already covered in earlier sections of the bill).

Changed the bill title from 'Raised Bill' to 'Substitute Bill' and updated the LCO number from 5921 to reflect the substitute version.

Floor votes · Senate Jun 4, 2025 · House Jun 4, 2025

How they voted

32–4
Passed
Total votes 36
Jun 4, 2025
D Democratic25
25 Yea
100% Yea
R Republican11
7 Yea 4 Nay
63% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
35
Key actions
10
Committee
6
Amendments
2
Jul 8, 2025
Signed into law
SIGNED BY GOVERNOR
lower
Jun 4, 2025
Upper · Passed
SEN. PASSED, HO. AMEND. SCH. A
upper
Jun 4, 2025
Upper · Passed
SEN. ADOPTED HO. AMEND. SCH. A
upper
Jun 4, 2025
Lower · Passed
HOUSE PASSED, HOUSE AMEND. SCH. A
lower
Jun 4, 2025
Lower · Passed
HOUSE ADOPTED HOUSE AMEND. SCH. A
lower
May 5, 2025
Lower · Passed
Joint Favorable Substitute
lower
Apr 29, 2025
Lower · Passed
REF. BY HOUSE TO COMMITTEE ON Appropriations
lower
Apr 15, 2025
Lower · Passed
Joint Favorable
lower
Apr 8, 2025
Lower · Passed
REF. BY HOUSE TO COMMITTEE ON Insurance and Real Estate
lower
Mar 14, 2025
Lower · Passed
Joint Favorable
lower
Mar 6, 2025
Committee
REF. TO JOINT COMM. ON Human Services
lower
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.